ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,709Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 625

$940K Total Retail Price of All Prescriptions

Rank: 33 out of 625

494 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,878 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 650 498 1 1
METFORMIN HCL 588 349 2 10
PRAVASTATIN SODIUM 520 325 3 8
FUROSEMIDE 514 375 4 7
HYDROCHLOROTHIAZIDE 394 283 5 12
HYDROCODONE-ACETAMINOPHEN 379 239 S3 6 4
METOPROLOL TARTRATE 352 285 7 11
CARVEDILOL 313 192 8 23
LISINOPRIL 308 238 9 5
OMEPRAZOLE 279 180 10 6
RANITIDINE HCL 267 191 11 25
LOVASTATIN 266 197 12 58
LEVOTHYROXINE SODIUM 258 165 13 3
SIMVASTATIN 238 197 14 2
DIOVAN 222 173 15 28
ZOLPIDEM TARTRATE 213 105 16 13
ATORVASTATIN CALCIUM 204 153 17 9
DIOVAN HCT 200 150 18 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 118 19 27
PREDNISONE 176 136 20 37
LANTUS 171 120 21 54
NOVOLOG FLEXPEN 169 104 22 151
LOSARTAN-HYDROCHLOROTHIAZIDE 165 119 23 38
ALLOPURINOL 160 128 24 29
METOPROLOL SUCCINATE 147 98 25 15
LANTUS SOLOSTAR 144 84 26 85
NEXIUM 143 94 27 21
INSULIN SYRINGE 135 84 28 77
GLIMEPIRIDE 132 96 29 42
AMITRIPTYLINE HCL 130 40 R 30 61
NOVOLOG 128 104 31 112
POTASSIUM CHLORIDE 126 75 32 19
DOXYCYCLINE HYCLATE 119 81 33 141
ISOSORBIDE MONONITRATE ER 115 72 34 49
CLOPIDOGREL 111 84 35 30
FAMOTIDINE 111 56 35 73
CLONIDINE HCL 110 66 37 50
PROAIR HFA 110 60 37 57
COLCRYS 106 92 39 117
ADVAIR DISKUS 104 69 40 63
ATENOLOL 97 77 41 22
GABAPENTIN 96 43 42 14
SERTRALINE HCL 95 81 43 26
CIPROFLOXACIN HCL 94 60 44 60
RISPERIDONE 92 70 45 92
OXYCODONE-ACETAMINOPHEN 88 39 S2 46 95
SPIRONOLACTONE 88 51 46 64
PROMETHAZINE HCL 87 62 R 48 84
WARFARIN SODIUM 86 47 49 20
CYCLOBENZAPRINE HCL 86 52 R 49 65
CITALOPRAM HBR 82 78 51 24
PLAVIX 81 54 52 43
TORSEMIDE 81 79 52 99
LOSARTAN POTASSIUM 80 53 54 18
PEN NEEDLE 79 33 55 100
ACTOS 79 55 55 102
DONEPEZIL HCL 77 77 57 33
TAMSULOSIN HCL 75 60 58 36
ENALAPRIL MALEATE 73 24 59 81
AMLODIPINE BESYLATE-BENAZEPRIL 70 46 60 48
AZITHROMYCIN 69 45 61 40
PHENYTOIN SODIUM EXTENDED 69 37 61 119
VENTOLIN HFA 68 42 63 93
DIGOXIN 66 49 64 55
GLIPIZIDE 65 65 65 56
RAMIPRIL 64 55 66 78
METFORMIN HCL ER 64 57 66 41
NAMENDA 64 64 66 45
KLOR-CON M20 62 62 69 47
TRAMADOL HCL 60 38 70 16
POLYETHYLENE GLYCOL 3350 60 39 70 82
FLUOXETINE HCL 55 0 72 62
COMBIVENT 53 48 73 126
MECLIZINE HCL 53 52 73 113
GLYBURIDE-METFORMIN HCL 52 45 R 75 125
NOVOLOG MIX 70-30 52 18 75 187
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.